Tylon Pharma Limited - pharma in Tarapur, Maharashtra, India. FY 2026 financials & compliance.
CIN U52609MH2022PLC390911 Incorporated 21 September 2022 ROC Mumbai HQ Tarapur, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹8.28 Cr
▲ 448.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7 Lakh
Issued & subscribed
Open charges
₹2.3 Cr
Satisfied ₹2.3 Cr
Company age
4 yrs
Est. 2022
Last financials
Mar 2025
Balance sheet date

About Tylon Pharma Limited

Data last updated:

Tylon Pharma Limited is a public limited company based in Tarapur, Maharashtra, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 21 September 2022.

Registered with ROC Mumbai under CIN U52609MH2022PLC390911.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Rajkumari Devendraprasad Tiwari and Indrakumar Tiwari.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: T – 89 Po Midc Tarapur Tal Palghar Dist Thane Midc Boisar, Maharashtra, India – 401506.

As per the financials filed for FY 2024, the company reported a revenue of ₹8.28 Cr, reflecting significant growth compared to the previous year.

The company is associated with 1 brand - Tylon Pharma. As per MCA filings, the company has open charges of ₹2.3 Cr and satisfied charges of ₹2.3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tylonpharma.com.

Company Details of Tylon Pharma Limited
CIN U52609MH2022PLC390911
Registration Number 390911
Incorporation Date 21 September 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    T – 89 Po Midc Tarapur Tal Palghar Dist Thane Midc Boisar, Maharashtra, India – 401506
  • Industry
    Pharma, Drug Formulation & Development
Company report
Tylon Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Tylon Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Tylon Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Tylon Pharma

Tylon Pharma has one previous CIN (Corporate Identification Number): U52609MH2022PTC390911. The current CIN is U52609MH2022PLC390911, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U52609MH2022PLC390911Current
U52609MH2022PTC390911Previous

Associated Brands with Tylon Pharma

Tylon Pharma operates one associated brand: Tylon Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Develops, manufactures, and markets pharmaceutical formulations for therapeutic areas globally.tylonpharma.com

Competitors & Alternatives of Tylon Pharma

Brands and companies operating in the same space as Tylon Pharma Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

CompetitorDescriptionLocationFounded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology companyHyderabad, India, India2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured.Indore, India, India2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured.Beijing, China, China2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered.Dudley, United Kingdom, United Kingdom2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals.Marseille, France, France1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research.Mumbai, India, India1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service providerCambridge, United States, United States2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas.Bengaluru, India, India2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.Noida, India, India1978

Business Activity of Tylon Pharma

The main business activity of Tylon Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details for Tylon Pharma Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Tylon Pharma

Tylon Pharma Limited is audited by BOHARA SHAH & CO for the financial year 2023.

NameStatusAppointment DateCessation Date
BOHARA SHAH & COLockedLockedLocked
Premium access

Complete auditor history for Tylon Pharma Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Tylon Pharma Limited

Tylon Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajkumari Devendraprasad TiwariDirector21 Sep 20224 Years 0 MonthsCurrent
Indrakumar TiwariDirector21 Sep 20224 Years 0 MonthsCurrent
Neelam Atmaram MishraDirector28 Aug 20242 Years 1 MonthsCurrent

Financials of Tylon Pharma Limited FY 2025 filings available

Tylon Pharma Limited reported revenue of ₹8.28 Cr (up 448.00% YoY) for FY 2024.

Revenue · FY 2024
₹8.28 Cr ▲ 448.00%
Premium access

Ten-year financial statements for Tylon Pharma Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Tylon Pharma

Premium access

Shareholding and ownership data for Tylon Pharma Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Tylon Pharma

Open charges
₹2.3 Cr
Satisfied charges
₹2.3 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.30 Cr
Latest charge details
DateLenderAmountStatus
14 Nov 2025Hdfc Bank Limited₹2.3 CrOpen
31 Jul 2023Bank of India₹2.3 CrSatisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Tylon Pharma

Tylon Pharma Limited has a workforce of 0 employees as of Mar 28, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Tylon Pharma Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Tylon Pharma

Premium access

GST registrations and filing compliance for Tylon Pharma Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Tylon Pharma

Premium access

Credit ratings, litigation, and regulatory alerts for Tylon Pharma Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Tylon Pharma

Premium access

MSME payment history for Tylon Pharma Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Tylon Pharma

Premium access

Corporate group structure for Tylon Pharma Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Tylon Pharma

Premium access

MCA filings and documents for Tylon Pharma Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Tylon Pharma

Charges
15 Nov 2025
A charge registered on 31 Jul 2023 via Charge ID 100762367 with Bank Of India was fully satisfied on 15 Nov 2025.
Charges
14 Nov 2025
A charge with Hdfc Bank Limited amounted to Rs. 230.00 Lakh with Charge ID 101189785 was registered on 14 Nov 2025.
Activity
30 Sep 2025
Tylon Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Tylon Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
28 Aug 2024
Neelam Atmaram Mishra was appointed as a Director on 28 Aug 2024 & has been associated with this company since 2 years 1 month.
Charges
31 Jul 2023
A charge with Bank Of India amounted to Rs. 230.00 Lakh with Charge ID 100762367 was registered on 31 Jul 2023.

Frequently Asked Questions about Tylon Pharma Limited

Tylon Pharma is an active public limited company in the pharma sector based in Tarapur, Maharashtra, India. It was incorporated on 21 September 2022 (4+ years old) and is registered under CIN U52609MH2022PLC390911.

Tylon Pharma reported revenue of ₹8.28 Cr for FY 2024 (up 448.00% YoY).

The current directors of Tylon Pharma are:

The primary industry of Tylon Pharma is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Tylon Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Tylon Pharma can be reached at the registered office: T – 89 Po Midc Tarapur Tal Palghar Dist Thane Midc Boisar, Maharashtra, India – 401506, or through the website tylonpharma.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available